T. Rowe Price Associates’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q2 | – | Sell |
-300,562
| Closed | -$16.1M | – | 2594 |
|
|
2016
Q1 | $16.1M | Sell |
300,562
-4,963
| -2% | -$265K | ﹤0.01% | 1153 |
|
|
2015
Q4 | $34.5M | Buy |
305,525
+157,225
| +106% | +$17.8M | 0.01% | 902 |
|
|
2015
Q3 | $17.5M | Buy |
148,300
+8,600
| +6% | +$1.01M | ﹤0.01% | 1136 |
|
|
2015
Q2 | $10.8M | Buy |
139,700
+52,600
| +60% | +$4.07M | ﹤0.01% | 1325 |
|
|
2015
Q1 | $5.04M | Buy |
+87,100
| New | +$5.04M | ﹤0.01% | 1470 |
|
|
2013
Q4 | – | Sell |
-100,000
| Closed | -$1.06M | – | 2589 |
|
|
2013
Q3 | $1.06M | Sell |
100,000
-62,187
| -38% | -$660K | ﹤0.01% | 1653 |
|
|
2013
Q2 | $907K | Buy |
+162,187
| New | +$907K | ﹤0.01% | 1682 |
|